Delivery Order HHSN271201700014I-75N95019F00089

Award Date 8/1/19
Potential Completion Date 11/30/23
Potential Value $1M
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $268,799.00 delivery order contract to Sri International for non-clinical safety assessment of ORC-13661 to support aminoglycoside induced hearing loss indication. Sri International will perform the work as the prime contractor in West Menlo Park, California from September 14, 2022 through November 13, 2023. Bioivt, LLC will serve as a subcontractor providing a...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River...
This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The contract is for an oral therapy for the prevention and treatment of malaria, with a period of performance from September 16, 2020 to March 15, 2021. The contract has a potential value of $439,121.00 and is a Cost Plus Fixed Fee type. The contract is not...
This is a task order award under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract held by Sri International, a nonprofit research and development institute. The task order, valued at $4,199,188, is for the National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services, to obtain toxicology services from Sri International. The task order has an ultimate...
This $2,546,927.00 federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to the prime contractor SRI International. The contract is a Delivery Order under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract. The contract has a Period of Performance through September 19, 2024 and does not utilize a...
This federal contract award is for "FOLLOW-ON 28 DAY DOG PHARMACOKINETIC AND CLINICAL CHEMISTRY ASSESSMENTS" and was issued by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Sri International, a non-profit research institute. The contract is a Delivery Order under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a potential...
This is a task order award under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract with the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $2,909,141.00 task order is for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" and has a completion date of May 19, 2022. The prime contractor is Sri International, a non-profit research institute that provides a...
This is a $756,613.00 firm fixed-price delivery order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services (HHS), to Sri International, a non-profit research and development institute. The award is for Task Order #001 under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master indefinite delivery/indefinite quantity (IDIQ) contract, and covers management and operations support...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,668,608 cost plus fixed fee delivery order contract to Sri International for pre-clinical, microbiological, safety, toxicology, and pharmacokinetic services. Sri International will perform this work in West Menlo Park, California from February 15, 2023 through February 14, 2024. Bioivt, LLC will provide transporter studies services and Charles River...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $1,027,022.00 cost-plus-fixed-fee delivery order contract to Sri International, a non-profit research institute, for non-clinical safety assessment of the drug candidate VK4-116 to support the treatment of severe pain disorders in human patients. This contract is part of the NCATS "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" indefinite delivery vehicle (IDV). Sri International has subcontracted a portion of the work to Nova Research Laboratories LLC, a small disadvantaged business, to conduct a GLP hERG assay. The contract does not utilize any set-aside provisions and has a completion date of November 30, 2023.

Generated 3/24/24, 2:45 AM